Cbay stock forecast.

Sector. Consumer Non-Durables. Industry. Food: Specialty/Candy. No executives to display. Corporate headquarters. --, --. Find real-time BROS - Dutch Bros Inc stock quotes, company profile, news ...Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...Nov 13. 4.17%. $94.57. Check if AHPI Stock has a Buy or Sell Evaluation. AHPI Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Allied Healthcare Products News.Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...Nov 29, 2023 · Predictions of CBAY stock price for tomorrow. 14-day Premium Trial Subscription Try For Free Get Free

CBM Bancorp, Inc. (CBMB) share price prediction for 2023, 2024, 2025, 2026 and 2027. CBMB one year forecast. CBM Bancorp stock monthly and weekly forecasts.The current average CBAY price target, as estimated by these analysts, is $0.00. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, …LifeSci Capital analyst Patrick Dolezal has maintained their bullish stance on CBAY stock, giving a Buy rating yesterday. Patrick Dolezal has given his Buy rating due to a combination of factors ...

Industry. Packaged Software. No executives to display. Corporate headquarters. Austin, Texas. Find real-time APPS - Digital Turbine Inc stock quotes, company profile, news and forecasts from CNN ...

PTC Therapeutics Inc. -3.71%. $1.57B. CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Based on short-term price targets offered by 11 analysts, the average price target for CymaBay Therapeutics Inc. comes to $24.45. The forecasts range from a low of $20.00 to a high of $34.00.Their CBAY share price targets range from $12.00 to $34.00. On average, they anticipate the company's stock price to reach $22.27 in the next year. This suggests a possible upside of 24.4% from the stock's current price. View analysts price targets for CBAY or view top-rated stocks among Wall Street analysts.Apr 26, 2023 · (See CBAY stock forecast) Cerevel Therapeutics . The next Edelman choice is Cerevel, a company established in 2018 that specializes in the field of neuroscience. Cerevel’s focus is on the ... The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low.

Their UBER share price targets range from $41.00 to $72.00. On average, they anticipate the company's stock price to reach $56.72 in the next twelve months. This suggests that the stock has a possible downside of 1.7%. View analysts price targets for UBER or view top-rated stocks among Wall Street analysts.

Oct 15, 2020 · About the CymaBay Therapeutics, Inc. stock forecast. As of 2023 November 25, Saturday current price of CBAY stock is 19.100$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).

1 Wall Street research analysts have issued 12 month price objectives for Genus' shares. Their GNS share price targets range from GBX 4,500 to GBX 4,500. On average, they anticipate the company's stock price to reach GBX 4,500 in the next year. This suggests a possible upside of 126.4% from the stock's current price.UBS has decided to maintain its Buy rating of CymaBay Therapeutics (NASDAQ:CBAY) and raise its price target from $18.00 to $25.00. Shares of CymaBay Therapeutics are trading up 7.26% over the last ...CBAY is a biopharmaceutical company that develops and commercializes new medicines for important human diseases. The stock price, earnings, news, and research reports of CBAY are available on Zacks. See the latest Zacks Rank, Style Scores, EPS Surprise, and more for CBAY.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Overview Stock Screener Earnings Calendar Sectors Nasdaq CBAY U.S.: Nasdaq CymaBay Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 15, 2023 7:49 p.m. EST...

CPG Stock 12 Months Forecast. Based on 10 Wall Street analysts offering 12 month price targets for Crescent Point Energy in the last 3 months. The average price target is C$14.80 with a high forecast of C$19.00 and a low forecast of C$13.00. The average price target represents a 53.50% change from the last price of C$9.64.Cymabay Therapeutics (CBAY) Company Description. CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral ...CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... A price increase of 41.9% over the past four weeks ensures that the trend is still in place for the stock of this company. Moreover, CBAY is currently trading at 92.9% of its 52-week High-Low ...The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. ... The 29 analysts offering price forecasts for CymaBay Therapeutics have ...

Sep 8, 2023 · CymaBay (CBAY) Stock Up on Positive Results From PBC Study. ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. According to the issued ratings of 7 analysts in the last year, the consensus rating for Verastem stock is Buy based on the current 7 buy ratings for VSTM. The average twelve-month price prediction for Verastem is $29.71 with a high price target of $36.00 and a low price target of $21.00. Learn more on VSTM's analyst rating history.

7 brokers have issued 12-month price targets for Verastem's stock. Their VSTM share price targets range from $21.00 to $36.00. On average, they anticipate the company's share price to reach $29.71 in the next year. This suggests a possible upside of 362.1% from the stock's current price. View analysts price targets for VSTM or view top-rated ...Stock Price Forecast. The 14 analysts offering 12-month price forecasts for International Business Machines Corp have a median target of 145.00, with a high estimate of 179.00 and a low estimate ...Get CymaBay Therapeutics Inc (CBAY.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.1 brokerages have issued 12-month price targets for Tamarack Valley Energy's shares. Their TNEYF share price targets range from $2.25 to $4.25. On average, they anticipate the company's stock price to reach $3.30 in the next twelve months. This suggests a possible upside of 26.1% from the stock's current price.97.32M. MSFT. 374.51. -1.16%. 29.21M. View today's Cymabay Therapeu stock price and latest CBAY news and analysis. Create real-time notifications to follow any changes in the live stock price.The 12 analysts offering 1 year price forecasts for CBAY have a max estimate of — and a min estimate of —. Analyst rating Based on 13 analysts giving stock ratings to CBAY in the past 3 months.

Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...

Nov 29, 2023 · Future criteria checks 2/6. CymaBay Therapeutics is forecast to grow earnings and revenue by 47.6% and 61.6% per annum respectively. EPS is expected to grow by 45.7% per annum. Return on equity is forecast to be -57.1% in 3 years. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comhá 4 dias ... For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, ...ACIU Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for AC Immune SA in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 417.80% change from the last price of $3.09.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Cymabay Therapeutics Stock Chart and Share Price Forecast, Short-Term "CBAY" Stock Prediction for Next Days and Weeks Walletinvestor.com Cymabay Therapeutics Inc (CBAY) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 Track Cymabay Therapeutics Inc (CBAY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors18 brokers have issued twelve-month target prices for Coterra Energy's stock. Their CTRA share price targets range from $27.00 to $42.00. On average, they anticipate the company's stock price to reach $31.93 in the next year. This suggests a possible upside of 19.3% from the stock's current price.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Last month, Menold Daniel, the VP Finance of CBAY bought 15,500.00 shares for a total of $79,010.00. TipRanks has tracked 36,000 company insiders and found that a few of them are better than ...NextPlay Technologies, Inc. (NASDAQ:NXTP) announced its quarterly earnings results on Wednesday, January, 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The firm earned $4.20 million during the quarter, compared to the consensus estimate of $5.70 …

ETNB Stock 12 Months Forecast. Based on 9 Wall Street analysts offering 12 month price targets for 89bio in the last 3 months. The average price target is $31.38 with a high forecast of $39.00 and a low forecast of $25.00. The average price target represents a 271.36% change from the last price of $8.45.Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price.CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that the results from its RESPONSE Phase 3 registration study evaluating seladelpar, a potent, selective, orally-active delpar ...Instagram:https://instagram. schd ex dividend datenutanix earningsxxll stockritchie bros stock The current CymaBay Therapeutics [ CBAY] share price is $17.90. The Score for CBAY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. CBAY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the... vanguard target retirement fund 2025ess inc stock Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get... liberty mutual pet insurance reviews CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has fallen from $29.28 to $23.09 - a -21.14% decrease. Five analysts predict that CymaBay Therapeutics’s share price will fall in the coming year, reaching $10.00. This would represent a decrease of -56.69%.Cia Brasileira De Distr-pao De Acucar stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast CBD stock forecast for 2023 – 2027. Last updated: November 29, 2023. Are you interested in Companhia Brasileira de Distribuição stocks prediction? If yes, then on this page you will find useful …The current average CBAY price target, as estimated by these analysts, is $0.00. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.